NCT01851772 2021-01-12Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical CancerXoft, Inc.Phase NA Completed3 enrolled 6 charts
NCT00431561 2013-12-03Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade GliomaIsarna Therapeutics GmbHPhase 2 Completed141 enrolled